Published in Mol Syst Biol on December 11, 2015
Construction of a lncRNA-mediated feed-forward loop network reveals global topological features and prognostic motifs in human cancers. Oncotarget (2016) 0.76
Inhibition of miR-21 rescues liver regeneration after partial hepatectomy in ethanol-fed rats. Am J Physiol Gastrointest Liver Physiol (2016) 0.76
miR-958 inhibits Toll signaling and Drosomycin expression via directly targeting Toll and Dif in Drosophila melanogaster. Am J Physiol Cell Physiol (2016) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res (2002) 76.95
Prediction of mammalian microRNA targets. Cell (2003) 53.70
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 48.95
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
Identification of tissue-specific microRNAs from mouse. Curr Biol (2002) 34.55
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78
MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05
Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature (2012) 15.91
Clustering by passing messages between data points. Science (2007) 15.45
Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med (2006) 13.63
Diverse somatic mutation patterns and pathway alterations in human cancers. Nature (2010) 10.83
Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell (2009) 10.50
MicroRNA signatures in human ovarian cancer. Cancer Res (2007) 9.45
Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med (2008) 8.77
The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell (2007) 7.99
Endosome maturation. EMBO J (2011) 5.22
Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev (2009) 5.21
The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev (2007) 5.16
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A (2008) 4.79
Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature (2007) 4.70
MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol (2008) 4.45
Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One (2013) 4.31
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res (2005) 4.24
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res (2012) 3.48
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin Cancer Res (2009) 3.45
DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics (2009) 3.05
The gamma-subunit of the coatomer complex binds Cdc42 to mediate transformation. Nature (2000) 2.88
Early endosomes and endosomal coatomer are required for autophagy. J Cell Biol (2009) 2.69
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One (2008) 2.60
USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma. Cell (2011) 2.51
EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis (2010) 2.13
Enhanced identification and biological validation of differential gene expression via Illumina whole-genome expression arrays through the use of the model-based background correction methodology. Nucleic Acids Res (2008) 2.11
High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci U S A (2012) 2.03
Statistical methods of background correction for Illumina BeadArray data. Bioinformatics (2009) 1.99
AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc Natl Acad Sci U S A (2006) 1.98
Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol (1999) 1.96
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun (2015) 1.94
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med (1984) 1.76
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One (2013) 1.75
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. Oncogene (2010) 1.73
Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. PLoS Genet (2008) 1.64
miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat Commun (2013) 1.59
miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets. PLoS One (2012) 1.54
The clinical relevance of cancer cell lines. J Natl Cancer Inst (2013) 1.54
Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer. Cancer Res (2012) 1.51
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer (1987) 1.47
HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer. Cancer Res (2011) 1.28
Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. Cell Signal (2013) 1.22
MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene (2013) 1.19
MicroRNA expression profiles of trophoblastic cells. Placenta (2012) 1.18
OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS One (2013) 1.09
An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells. Mol Cancer (2011) 1.05
RhoJ regulates melanoma chemoresistance by suppressing pathways that sense DNA damage. Cancer Res (2012) 1.00
miR-181a promotes osteoblastic differentiation through repression of TGF-β signaling molecules. Int J Biochem Cell Biol (2012) 0.99
MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J Biol Chem (2010) 0.96
Six family genes control the proliferation and differentiation of muscle satellite cells. Exp Cell Res (2010) 0.95
Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines. Oncol Rep (2011) 0.93
Host modulators of H1N1 cytopathogenicity. PLoS One (2012) 0.91
siMacro: A Fast and Easy Data Processing Tool for Cell-Based Genomewide siRNA Screens. Genomics Inform (2013) 0.87
Model-Based Background Correction (MBCB): R Methods and GUI for Illumina Bead-array Data. J Cancer Sci Ther (2009) 0.87
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets. Mol Cancer (2014) 0.81
Optimized Prediction of Extreme Treatment Outcomes in Ovarian Cancer. Cancer Inform (2016) 0.75